Announce Date | 05/15/2025 |
EPS Normalized Actual | $-0.08 In Line |
EPS GAAP Actual | $-0.08 In Line |
Revenue Actual | $0.000197B |
Revenue Surprise | Beat by $0.197M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.1 |
EPS GAAP Estimate | $-0.1 |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.25 | 1.03 | 1.25 | 1.25 | 1 |
Dec 2028 | 1.175 | 1.09 | 1.175 | 1.175 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.08 | 0.02 | 0.000197B | 100% | 0.2M |
FQ4 2024 (Dec 2024) | -0.013 | 0.057 | 4.3E-5B | 100% | 0.04M |
FQ3 2024 (Sep 2024) | -0.0991 | -0.0191 | 0B | NAN% | 0M |
FQ2 2024 (Jun 2024) | -0.0001 | -1.34269 | 0B | NAN% | 0M |
FQ1 2024 (Mar 2024) | -0.072 | -1.64845 | 0B | NAN% | 0M |
FQ4 2023 (Dec 2023) | 0 | 0 | 0B | NAN% | 0M |
FQ3 2023 (Sep 2023) | -0.13 | -0.13 | 0B | NAN% | 0M |
FQ2 2023 (Jun 2023) | -0.22 | -0.22 | 0B | NAN% | 0M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.1
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | -0.06 | -- | -0.06 | -0.06 | 1 |
FQ2 2026 (Jun 2026) | -0.06 | -- | -0.06 | -0.06 | 1 |
FQ1 2026 (Mar 2026) | -0.07 | -14.29 | -0.07 | -0.07 | 1 |
FQ4 2025 (Oct 2025) | -0.1 | 87 | -0.1 | -0.1 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 1 |
FQ2 2026 (Jun 2026) | 0B | -- | 0B | 0B | 1 |
FQ1 2026 (Mar 2026) | 0B | 75.38 | 0B | 0B | 2 |
FQ4 2025 (Oct 2025) | 0B | -INF | 0B | 0B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
5
EPS # of in-lines
1
Revenue # of Beats
2
Revenue # of Misses
0
Revenue # of in-lines
6
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.1 | -0.08 | 0.02 | -25% |
FQ4 2024 (Dec 2024) | -0.07 | -0.013 | 0.057 | -438.46% |
FQ3 2024 (Sep 2024) | -0.08 | -0.0991 | -0.0191 | 19.27% |
FQ2 2024 (Jun 2024) | 1.34259 | -0.0001 | -1.34269 | 1342690% |
FQ1 2024 (Mar 2024) | 1.57645 | -0.072 | -1.64845 | 2289.51% |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | -0.13 | -0.13 | 100% | |
FQ2 2023 (Jun 2023) | -0.22 | -0.22 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0B | $0.2M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0B | $0.04M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
FQ3 2023 (Sep 2023) | $0B | $0B | $0M | NAN% |
FQ2 2023 (Jun 2023) | $0B | $0B | $0M | NAN% |